HTGC

HTGC

USD

Hercules Capital Inc. Common Stock

$17.910+0.065 (0.364%)

Цена в режиме реального времени

Финансовые услуги
Asset Management
Соединенные Штаты

График цен

Ключевые показатели

Рыночные показатели
Фундаментальные показатели компании
Статистические данные торговли

Рыночные показатели

Открытие

$17.845

Максимум

$18.010

Минимум

$17.840

Объем

0.14M

Фундаментальные показатели компании

Рыночная капитализация

3.1B

Отрасль

Asset Management

Страна

United States

Статистические данные торговли

Средний объем

1.33M

Биржа

NYQ

Валюта

USD

52-недельный диапазон

Минимум $15.65Текущая $17.910Максимум $22.04

Отчет об анализе ИИ

Последнее обновление: 28 апр. 2025 г.
Сгенерировано ИИИсточник данных: Yahoo Finance, Bloomberg, SEC

HTGC: Hercules Capital Inc. Common Stock - What's Happening and What to Watch

Stock Symbol: HTGC Generate Date: 2025-04-28 06:51:00

Alright, let's break down what's been going on with Hercules Capital (HTGC) based on the latest info. Think of this as looking at the puzzle pieces to see the picture.

Recent News Buzz - What's the Vibe?

Looking at the news from April, it's a bit of a mixed bag, honestly.

On the really good side, Hercules Capital got a significant upgrade! Fitch Ratings bumped their secured debt rating up to 'BBB'. That's investment grade, which is a solid positive signal. It basically means a major rating agency sees the company as more financially stable and less risky when it comes to paying back its debts. That's a big deal for a lender like Hercules.

Also positive, they announced a substantial financing deal, providing up to $500 million to MoonLake. This shows they're actively doing business and putting capital to work, which is their core function. Plus, it's "non-dilutive" for MoonLake, meaning Hercules is providing debt, not taking a chunk of MoonLake's ownership, which can be attractive for the companies they lend to.

Now, for the less sunny bits. A few analysts recently lowered their price targets for HTGC. UBS dropped theirs from $20 to $18, Keefe, Bruyette & Woods went from $21.50 to $20.50, and Piper Sandler moved from $23 to $20. While two of these firms still maintain positive ratings ("Outperform" and "Overweight"), the fact that they're trimming their targets suggests they see less potential upside in the near term than they did before.

So, the news vibe is a blend: strong fundamental positives like the rating upgrade and a big deal, but tempered by analysts becoming a little less bullish on the stock's immediate price potential.

Price Check - What's the Stock Been Doing?

Looking at the price chart over the last few months, it's been a bit of a rollercoaster, but the overall trend hasn't been great lately.

The stock was trading comfortably above $20 back in January and February, even hitting a peak around $21.50. Then, things took a noticeable turn lower in March, dropping into the $18-$19 range. April saw another leg down, with the price dipping significantly and spending time bouncing around between roughly $16 and $18.

The last few trading days show the price hovering right around the $17.50 to $17.90 area. The last recorded close was $17.91.

Comparing this to the AI's short-term predictions, the AI model forecasts slight dips over the next couple of days (-0.29%, -0.29%, then -1.08%). This suggests the AI sees a bit more downward pressure coming right away, which aligns somewhat with the recent price trend staying below its earlier highs.

Putting It Together - Outlook & Ideas

So, what does all this suggest?

You've got a company getting a significant vote of confidence from a rating agency (Fitch upgrade) and actively deploying capital (MoonLake deal). These are fundamentally good things. However, the stock price has been trending down for a couple of months, and analysts have been pulling back their near-term price expectations. The AI prediction also points to a slight dip coming up.

Based on this mix, the apparent near-term leaning seems cautious. While the underlying business news is positive, the recent price action and analyst target cuts suggest the market might be digesting something else, or perhaps the broader market conditions are weighing on the stock. It doesn't scream "jump in now" based purely on the price trend and AI prediction, despite the good news on the rating front.

  • Potential Entry Consideration: If someone were interested in HTGC because of the positive fundamental news (like the rating upgrade) and felt the recent price drop offered a better value, they might look at the recent trading range for ideas. The recommendation data points to potential entry levels around $17.87 or $17.93, which is right where the stock last closed. However, given the AI predicts a slight dip, a more cautious approach might be to wait and see if it pulls back a bit more, perhaps towards the lower end of the recent $16-$18 range, though there's no guarantee it will reach those levels. The recommendation data's technical signals (like the OBV surge and MACD cross) do suggest some buying pressure recently, which could support an entry around current levels if you weigh technicals heavily.
  • Potential Exit/Stop-Loss Consideration: Managing risk is key. The recommendation data suggests a potential stop-loss level at $17.17. This makes sense as it's below the recent cluster of trading and could signal that the recent stability is breaking down. For taking profits, the recommendation data suggests $18.27. This is just above the recent trading range highs and could be a level where the stock meets some resistance. These are just potential levels to consider for managing a position.

Company Context

Remember, Hercules Capital is a specialty finance company. They lend money to venture-backed tech and life sciences companies. This means their business performance is tied to the health of the venture capital world and the success of the startups they fund. The Fitch rating upgrade is particularly relevant because it speaks directly to their financial strength as a lender. Deals like the one with MoonLake are core to their operation.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Связанные новости

Analyst Upgrades

UBS Maintains Neutral on Hercules Capital, Lowers Price Target to $18

UBS analyst Vilas Abraham maintains Hercules Capital with a Neutral and lowers the price target from $20 to $18.

Просмотреть больше
UBS Maintains Neutral on Hercules Capital, Lowers Price Target to $18
BusinessWire

Hercules Capital Announces Date for Release of First Quarter 2025 Financial Results and Conference Call

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and

Просмотреть больше
Hercules Capital Announces Date for Release of First Quarter 2025 Financial Results and Conference Call
BusinessWire

Correction: Hercules Capital Receives Secured Debt Rating Upgrade to BBB from Fitch Ratings, Inc.

This press release corrects, replaces and entirely supersedes a prior version published on April 16, 2025. Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing

Просмотреть больше
Correction: Hercules Capital Receives Secured Debt Rating Upgrade to BBB from Fitch Ratings, Inc.
BusinessWire

Hercules Capital Receives Investment Grade Rating Upgrade to BBB from Fitch Ratings, Inc.

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and

Просмотреть больше
Hercules Capital Receives Investment Grade Rating Upgrade to BBB from Fitch Ratings, Inc.
Analyst Upgrades

Keefe, Bruyette & Woods Maintains Outperform on Hercules Capital, Lowers Price Target to $20.5

Keefe, Bruyette & Woods analyst Paul Johnson maintains Hercules Capital with a Outperform and lowers the price target from $21.5 to $20.5.

Просмотреть больше
Keefe, Bruyette & Woods Maintains Outperform on Hercules Capital, Lowers Price Target to $20.5
Analyst Upgrades

Piper Sandler Maintains Overweight on Hercules Capital, Lowers Price Target to $20

Piper Sandler analyst Crispin Love maintains Hercules Capital with a Overweight and lowers the price target from $23 to $20.

GlobeNewswire

MoonLake Secures up to $500 Million in Non-Dilutive Financing from Hercules Capital and Announces a Capital Markets Update on April 29 to Provide Important Clinical Updates

Agreement with Hercules Capital significantly increases financial and operational strength, provides up to $500 million in capital with no dilution to shareholders, an attractive cost of capital and low operational and

Прогноз ИИBeta

Рекомендация ИИ

Медвежий

Обновлено в: 27 апр. 2025 г., 22:49

МедвежийНейтральныйБычий

64.0% Уверенность

Риск и торговля

Уровень риска3/5
Средний риск
Подходит для
Стоимость
Руководство по торговле

Точка входа

$17.87

Взять прибыль

$18.27

Остановить убытки

$17.17

Ключевые факторы

PDI 3.8 выше MDI 3.4 с ADX 6.6, что предполагает бычий тренд
Текущая цена очень близка к уровню поддержки ($17.90), что предполагает сильную возможность покупки
Объем торгов в 5.6 раз превышает среднее значение (18,186), что указывает на чрезвычайно сильное покупательское давление
MACD -0.0021 выше сигнальной линии -0.0047, что указывает на бычье пересечение

Оставаться в курсе

Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.